New guidelines for imaging estrogen receptor in breast cancer patients using FES PET

The newly secured capital will be utilised to expand the Phase I/II trial of GRWD5769 for solid tumour types. Credit: Gorodenkoff/ Shutterstock.com. Grey Wolf Therapeutics

Some “unusual” cancers emerged during the pandemic, but is COVID to blame? (Washington Post) Using routinely collected information about patients with cancer, an artificial intelligence